Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
D000361:Agammaglobulinemia / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D002513:Cephamycins / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D002552:Cerebral Ventricles; D004660:Encephalitis / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D009070:Moxalactam; D012008:Recurrence
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002513:Cephamycins; D009070:Moxalactam